Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joseph P. Hagan currently holds 990,000 shares of Regulus Therapeutics Inc. (RGLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph P. Hagan has been a net seller of RGLS stock. They have purchased $353.2K and sold $2.2M worth of shares.
Joseph P. Hagan's most recent insider trade was on May 20, 2024, when they sold 990,000 shares at $0.00 per share.
Joseph P. Hagan serves as Executive at Regulus Therapeutics Inc. (RGLS). They have executed 53 insider transactions totaling $2.6M over their tenure at the company.
Joseph P. Hagan holds the position of Executive at Regulus Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Joseph P. Hagan has shown a selling trading pattern, with $353.2K in total purchases and $2.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joseph P. Hagan was on Jan 3, 2022, when they sold $888.9K worth of AUPH shares. This transaction involved 39,366 shares at $22.58 per share.
Joseph P. Hagan currently owns 990,000 shares of Regulus Therapeutics Inc. (RGLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joseph P. Hagan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph P. Hagan has 53 Form 4 filings on record as an insider at Regulus Therapeutics Inc..
Set alerts for Joseph P. Hagan and 40,000+ other insiders.